SCHEMBL23309585

SCHEMBL23309585

O=C(Nc1cccc(Oc2ccccc2)c1)c1cc(F)nc(F)c1F

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.52
▸ RAB9A P51151 3/20 0.50
▸ MAPT P10636 2/20 0.50
▸ PLAU P00749 1/20 0.50
▸ LMNA P02545 1/20 0.50
▸ HPGD P15428 1/20 0.50
▸ NPC1 O15118 2/20 0.49
▸ MAPK1 P28482 2/20 0.49
▸ POLB P06746 2/20 0.49
▸ MITF O75030 1/20 0.49
▸ ALDH1A1 P00352 1/20 0.49
▸ HTT P42858 1/20 0.49
▸ KMT2A Q03164 3/20 0.48
▸ MEN1 O00255 2/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ HPSE Q9Y251 1/20 0.48
▸ KDR P35968 1/20 0.47
▸ NR1H4 Q96RI1 1/20 0.47
▸ GALK1 P51570 1/20 0.46
▸ CASP6 P55212 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309562 0.90 PNLIP (0.56) RAB9AMAPTLMNAHPGDNPC1
SCHEMBL23309513 0.86 RAB9A (0.63) KDM4ERAB9ANPC1POLBALDH1A1
SCHEMBL23309490 0.86 GAA (0.51) KDM4ERAB9ALMNAHPGDNPC1
SCHEMBL23309593 0.85 GRM4 (0.52) KDM4ERAB9AMAPTPLAULMNA
SCHEMBL23309615 0.84 P2RX1 (0.58) RAB9AMAPTHPGDNPC1ALDH1A1
SCHEMBL23309612 0.83 GRM4 (0.47) KDM4ERAB9AMAPTLMNAHPGD
SCHEMBL23309511 0.83 KMT2A (0.52) RAB9AMAPTPLAULMNANPC1
SCHEMBL12190104 0.81 KDM4E (0.58) KDM4ERAB9AMAPTPLAULMNA
SCHEMBL23309548 0.80 FADS1 (0.55) KDM4ERAB9AMAPTLMNAHPGD
SCHEMBL23309536 0.80 MEN1 (0.55) KDM4ERAB9ALMNAHPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL KDM4E 3438/4885RAB9A 286/4885MAPT 1126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback